Dec 20, 2018
Starpharma’s US license for VivaGel® BV covered by Biotech Dispatch
Biotech Dispatch featured the news that Starpharma had signed a sales and marketing license agreement for VivaGel® BV for the US market with ITF Pharma. The piece highlighted that upon launch, VivalGel® BV will be ITF Pharma’s top priority women’s health product.
To read the article, click here.